MOTS-c and Retatrutide Interaction

Synergistic
Mechanism-based 51% confidence

MOTS-c and Retatrutide have a synergistic interaction with 51% confidence. MOTS-c helps counteract the insulin-disrupting effects of Retatrutide. A smart combination — the insulin sensitizer mitigates metabolic side effects. Both compounds affect the pancreas, so monitoring these systems is recommended.

Compound Profiles

MOTS-c

Mitochondrial-Derived Peptide | Metabolic Regulator

Inhibits the folate cycle leading to AMPK activation. Under metabolic stress, translocates to nucleus to bind stress-response transcription factors, regulating genes involved in metabolism, insulin sensitivity, and cellular adaptation.

Half-life: ~30 minutes Typical dose: Start 5mg daily, increase to 10-15mg based on goals longevity, metabolic
ampknrf2 insulin disruptinginsulin sensitizingteratogenic
View full profile

Retatrutide

Triple GLP-1/GIP/Glucagon Agonist | Weight Loss & Diabetes

Activates GLP-1 for appetite suppression, GIP for insulin sensitivity, and glucagon for increased energy expenditure and hepatic fat oxidation..

Half-life: ~6 days Typical dose: 0.5mg starting, titrate up to 8-12mg weekly weight loss, metabolic
insulin disrupting
View full profile

Combined Organ Load

Pancreas
low
GI Tract
low

Shared Safety Flags

2x 2 compounds affect insulin sensitivity (MOTS-c, Retatrutide). Monitor fasting glucose and HbA1c.

Frequently Asked Questions

Can I take MOTS-c with Retatrutide?

Yes, MOTS-c and Retatrutide can generally be taken together. MOTS-c helps counteract the insulin-disrupting effects of Retatrutide. A smart combination — the insulin sensitizer mitigates metabolic side effects.

Is MOTS-c and Retatrutide safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: insulin disrupting. Monitor accordingly.

What are the interactions between MOTS-c and Retatrutide?

MOTS-c helps counteract the insulin-disrupting effects of Retatrutide. A smart combination — the insulin sensitizer mitigates metabolic side effects. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.

How should I time MOTS-c and Retatrutide?

MOTS-c has a half-life of ~30 minutes and Retatrutide has a half-life of ~6 days. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: MOTS-c vs Retatrutide

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.